InvestorsHub Logo
Followers 0
Posts 8
Boards Moderated 0
Alias Born 09/28/2016

Re: None

Tuesday, 04/11/2017 7:48:25 PM

Tuesday, April 11, 2017 7:48:25 PM

Post# of 38634
Great news in my opinion...

"Should the Company secure final FDA approval on its generic Seroquel XR®ANDA and, in collaboration with its marketing and distribution partner Mallinckrodt, successfully launch all or some of the strengths in May 2017, then the Company may be cash flow positive in the third quarter of 2017.  Failing this, the Company may need to obtain additional funding prior to that time as we further the development of our product candidates and if we accelerate our product commercialization activities."